MedTrace Logo

PAP Therapy in Patients With Obesity Hypoventilation Syndrome

NCT03449641 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 252

Last updated 2018-03-01

No results posted yet for this study

Summary

The role of different levels of compliance and long-term effects of positive airway pressure (PAP) therapy on gas exchange, sleepiness, quality of life, depression and death rate in patients with obesity hypoventilation syndrome (OHS).

Conditions

  • Obesity Hypoventilation Syndrome

Interventions

DEVICE

Positive airway pressure (PAP)

Positive airway pressure (PAP) is a mode of respiratory ventilation used in the treatment of sleep apnea.

Sponsors & Collaborators

  • University of Crete

    lead OTHER

Principal Investigators

  • Sophia Schiza, MD, PhD · University of Crete

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-01
Primary Completion
2012-06-01
Completion
2012-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03449641 on ClinicalTrials.gov